[1]
E. Galli, M. P. Pedone, M. Dobreva, R. Bitonti, and R. Di Turi, “[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]”, FE, vol. 23, no. 1, Jun. 2022.